Possible mechanisms underlying the development of cachexia in COPD
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
About 25% of patients with chronic obstructive pulmonary disease (COPD) will develop cachexia (fat-free body mass index <17 kg·m−2(males) or <14 kg·m−2(females)). This is associated with ∼50% reduction in median survival. The pathogenetic mechanism has been variously suggested to result from the following: 1) energy imbalance; 2) disuse atrophy; 3) tissue hypoxia from arterial hypoxaemia; 4) systemic inflammation; and 5) anabolic hormonal insufficiency. Genetic polymorphisms implicate inflammatory cytokines, especially interleukin (IL)-1β, but IL-6 and tumour necrosis factor (TNF)-α do not show polymorphisms in these patients. Early reports of elevated TNF-α levels suggested a role for inflammation, but recent studies have not shown elevated levels of either IL-6 or TNF-α. Therapeutic trials of nutritional support, hormonal supplementation, anti-TNF-α immunotherapy, ghrelin and antioxidants have been conducted, but only a few have shown any benefits in muscle structure and function. Considerably more mechanistic knowledge is needed before therapeutic recommendations can be made. At this time, it is not possible to attribute cachexia in COPD unequivocally to inflammation or any other cause, and much more research is needed. To date, studies have been predominantly cross-sectional, with measurements made only after cachexia has developed. Future research should target prospective observation, studying patients as cachexia progresses, since once cachexia is established, inflammatory cytokine levels may not be abnormal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Body composition and mortality in chronic obstructive pulmonary disease
Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.53 · Cited by 902
Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.
Grunfeld, C., Zhao, C., Fuller, J., Pollack, A., Moser, A., Friedman, J., & Feingold, K. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118653 · Cited by 862
Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J., Flier, J. S., Lowell, B. B., Fraker, D. L., & Alexander, H. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.171 · Cited by 791 · cited 1×
“It has also been reported that inflammatory cytokines actually stimulate leptin [42, 43 ]; ordinarily, this would be expected to raise and not lower weight.”
BackgroundCachexia: pathophysiology and clinical relevance1,2
Morley, J. E., Thomas, D. R., & Wilson, M.-M. G. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.735 · Cited by 786
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Fat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Alveolar Cell Senescence in Patients with Pulmonary Emphysema
Tsuji, T., Aoshiba, K., & Nagai, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1374oc · Cited by 527
Thomas, D. R. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.03.008 · Cited by 521 · cited 1×
“Since ageing is associated with loss of lean body mass [ 50 ], it is possible that those subjects with COPD who develop cachexia are those who, in the absence of their disease, would have shown accelerated ageing and loss of lean body mass.”
BackgroundLi, Y.-P., Schwartz, R. J., Waddell, I. D., Holloway, B. R., & Reid, M. B. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.871 · Cited by 499
Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.
Di Francia, M., Barbier, D., Mege, J. L., & Orehek, J. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.5.7952575 · Cited by 485
Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease
EID, A. A., IONESCU, A. A., NIXON, L. S., LEWIS-JENKINS, V., MATTHEWS, S. B., GRIFFITHS, T. L., & SHALE, D. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2008109 · Cited by 376
TAKABATAKE, N., NAKAMURA, H., ABE, S., INOUE, S., HINO, T., SAITO, H., YUKI, H., KATO, S., & TOMOIKE, H. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9903022 · Cited by 327
Telomere shortening in smokers with and without COPD
Morlá, M., Busquets, X., Pons, J., Sauleda, J., MacNee, W., & Agustí, A. G. N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00087005 · Cited by 326
Cigarette smoke induces cellular senescence
Nyunoya, T., Monick, M. M., Klingelhutz, A., Yarovinsky, T. O., Cagley, J. R., & Hunninghake, G. W. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0169oc · Cited by 306
Treatment of Cachexia With Ghrelin in Patients With COPD
Nagaya, N., Itoh, T., Murakami, S., Oya, H., Uematsu, M., Miyatake, K., & Kangawa, K. (2005) · Chest · doi:10.1378/chest.128.3.1187 · Cited by 295
Neurohumoral activation as a link to systemic manifestations of chronic lung disease
Andreas, S., Anker, S. D., Scanlon, P. D., & Somers, V. K. (2005) · Chest · doi:10.1378/chest.128.5.3618 · Cited by 243
DEBIGARÉ, R., CÔTÉ, C. H., & MALTAIS, F. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2104035 · Cited by 231
BURDET, L., de MURALT, B., SCHUTZ, Y., PICHARD, C., & FITTING, J.-W. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9704142 · Cited by 225
SCHOLS, A. M. W. J., CREUTZBERG, E. C., BUURMAN, W. A., CAMPFIELD, L. A., SARIS, W. H. M., & WOUTERS, E. F. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.4.9811033 · Cited by 214
A Role for Anabolic Steroids in the Rehabilitation of Patients With COPD? *
Creutzberg, E. C., Wouters, E. F. M., Mostert, R., Pluymers, R. J., & Schols, A. M. W. J. (2003) · Chest · doi:10.1378/chest.124.5.1733 · Cited by 213
NF- B activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight
Agusti, A. (2004) · Thorax · doi:10.1136/thx.2003.017640 · Cited by 205
Circulating Leptin in Patients with Chronic Obstructive Pulmonary Disease
TAKABATAKE, N., NAKAMURA, H., ABE, S., HINO, T., SAITO, H., YUKI, H., KATO, S., & TOMOIKE, H. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9806134 · Cited by 204
Does Oxidative Stress Alter Quadriceps Endurance in Chronic Obstructive Pulmonary Disease?
Koechlin, C., Couillard, A., Simar, D., Cristol, J. P., Bellet, H., Hayot, M., & Prefaut, C. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1465oc · Cited by 192
RABINOVICH, R. A., ARDITE, E., TROOSTERS, T., CARBÓ, N., ALONSO, J., DE SUSO, J. M. G., VILARÓ, J., BARBERÀ, J. A., POLO, M. F., ARGILÉS, J. M., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2103065 · Cited by 190
CREUTZBERG, E. C., SCHOLS, A. M. W. J., WELING-SCHEEPERS, C. A. P. M., BUURMAN, W. A., & WOUTERS, E. F. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9808075 · Cited by 187
Lung fibroblasts from patients with emphysema show markers of senescence in vitro
Müller, K.-C., Welker, L., Paasch, K., Feindt, B., Erpenbeck, V., Hohlfeld, J., Krug, N., Nakashima, M., Branscheid, D., Magnussen, H., et al. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-32 · Cited by 173
RICHARDSON, R. S., SHELDON, J., POOLE, D. C., HOPKINS, S. R., RIES, A. L., & WAGNER, P. D. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.3.9803049 · Cited by 163
Self-citationControl of Muscle Size During Disuse, Disease, and Aging
Degens, H., & Alway, S. E. (2006) · International Journal of Sports Medicine · doi:10.1055/s-2005-837571 · Cited by 156
A Novel Pathophysiologic Phenomenon in Cachexic Patients with Chronic Obstructive Pulmonary Disease
Takabatake, N., Nakamura, H., Minamihaba, O., Inage, M., Inoue, S., 加賀谷, 茂., Yamaki, M., & Tomoike, H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.6.2004175 · Cited by 155
SAULEDA, J., GARCÍA-PALMER, F., WIESNER, R. J., TARRAGA, S., HARTING, I., TOMÁS, P., GÓMEZ, C., SAUS, C., PALOU, A., & AGUSTÍ, A. G. N. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9710039 · Cited by 154
Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease
Fuld, J. P. (2005) · Thorax · doi:10.1136/thx.2004.030452 · Cited by 145
Elevated Plasma Ghrelin Level in Underweight Patients with Chronic Obstructive Pulmonary Disease
Itoh, T., Nagaya, N., Yoshikawa, M., Fukuoka, A., Takenaka, H., Shimizu, Y., Haruta, Y., Oya, H., Yamagishi, M., Hosoda, H., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1404oc · Cited by 141
Exercise-Induced Systemic Effects in Muscle-Wasted Patients with COPD
VAN HELVOORT, H. A. C., HEIJDRA, Y. F., THIJS, H. M. H., VIÑA, J., WANTEN, G. J. A., & DEKHUIJZEN, P. N. R. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000228331.13123.53 · Cited by 140
First Study of Infliximab Treatment in Patients with Chronic Obstructive Pulmonary Disease
van der Vaart, H., Koëter, G. H., Postma, D. S., Kauffman, H. F., & ten Hacken, N. H. T. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-147oc · Cited by 140
Muscle Wasting and Impaired Muscle Regeneration in a Murine Model of Chronic Pulmonary Inflammation
Langen, R. C. J., Schols, A. M. W. J., Kelders, M. C. J. M., van der Velden, J. L. J., Wouters, E. F. M., & Janssen-Heininger, Y. M. W. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0103oc · Cited by 137
Weight Loss is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
Schols, A. M., Slangen, J., Volovics, L., & Wouters, E. F. (1999) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199907000-00014 · Cited by 133
Ottenheijm, C. A. C., Heunks, L. M. A., Li, Y.-P., Jin, B., Minnaard, R., van Hees, H. W. H., & Dekhuijzen, P. N. R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-721oc · Cited by 127
Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease
Hopkinson, N. S., Nickol, A. H., Payne, J., Hawe, E., Man, W. D.-C., Moxham, J., Montgomery, H., & Polkey, M. I. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-578oc · Cited by 116
Endocrinological disturbances in chronic obstructive pulmonary disease
Creutzberg, E. C., & Casaburi, R. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00004610 · Cited by 114
Sergi, G., Coin, A., Marin, S., Vianello, A., Manzan, A., Peruzza, S., Inelmen, E. M., Busetto, L., Mulone, S., & Enzi, G. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.03.008 · Cited by 110
Anorexia in chronic obstructive pulmonary disease — Association to cachexia and hormonal derangement
Koehler, F., Doehner, W., Hoernig, S., Witt, C. C., Anker, S. D., & John, M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.088 · Cited by 110
Broekhuizen, R., Grimble, R. F., Howell, W. M., Shale, D. J., Creutzberg, E. C., Wouters, E. F. �., & Schols, A. M. W. J. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.1059 · Cited by 108
Rutten, E. P. A., Franssen, F. M. E., ENGELEN, M. P. K. J., Wouters, E. F. �., Deutz, N. E. P., & Schols, A. M. W. J. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.829 · Cited by 106
The pulmonary cachexia syndrome: aspects of energy balance
Congleton, J. (1999) · Proceedings of the Nutrition Society · doi:10.1017/s0029665199000439 · Cited by 105
Schols, A. M. W. J. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00238-3 · Cited by 100
Nutritional and metabolic modulation in chronic obstructive pulmonary disease management
Schols, A. M. W. J. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00004611 · Cited by 84
Weight Gain in Cachectic COPD Patients Receiving Noninvasive Positive-Pressure Ventilation
Budweiser, S., Heinemann, F., Meyer, K., Wild, P. J., & Pfeifer, M. (2006) · Respiratory Care · doi:10.4187/respcare.06510126 · Cited by 72
The Science of Megestrol Acetate Delivery: Potential to Improve Outcomes in Cachexia
Femia, R. A., & Goyette, R. E. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00004 · Cited by 67
Chronic obstructive pulmonary disease: effects beyond the lungs
Balasubramanian, V. P., & Varkey, B. (2006) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000208449.73101.ac · Cited by 65
Rabinovich, R. A., Ardite, E., Mayer, A. M., Polo, M. F., Vilaró, J., Argilés, J. M., & Roca, J. (2006) · Respiration · doi:10.1159/000094395 · Cited by 58
Systemic Inflammation in COPD: Is Genetic Susceptibility a Key Factor?
Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., & Wouters, E. F. �. (2006) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550500493436 · Cited by 57
Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease
Schols, A. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2003303 · Cited by 46
Farber, M. O., & Mannix, E. T. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70188-2 · Cited by 45
Hopkinson, N. S., Eleftheriou, K. I., Payne, J., Nickol, A. H., Hawe, E., Moxham, J., Montgomery, H., & Polkey, M. I. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.912 · Cited by 37
Apoptosis as a Potential Mechanism of Muscle Cachexia in Chronic Obstructive Pulmonary Disease
Lewis, M. I. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2205023 · Cited by 37
The use of melanocortin antagonists in cachexia of chronic disease
Scarlett, J. M., & Marks, D. L. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.10.1233 · Cited by 31
Sin, D. D., Man, S. P., Marciniuk, D. D., Ford, G. T., Fitzgerald, M., Wong, E. Y. L., York, E. L., Mainra, R., Ramesh, W., Melenka, L., et al. (2006) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-6-3 · Cited by 22
Hopkinson, N. S., Nickol, A. H., Payne, J., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.170.5.951 · Cited by 16
Yeh, S., Hafner, A., Schuster, M. W., Mantovani, G., Levine, D. M., & Parker, T. S. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1365-2389.2003.51282.x · Cited by 12
Orozco‐Levi, M., Lloreta, J., & Gea, J. (2006) · Ultrastructural Pathology · doi:10.1080/01913120600820146 · Cited by 5
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Skeletal muscle loss: cachexia, sarcopenia, and inactivity
Evans, W. J. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28608a · Cited by 723
Cavaillès, A., Brinchault-Rabin, G., Dixmier, A., Goupil, F., Gut-Gobert, C., Marchand-Adam, S., Meurice, J.-C., Morel, H., Person-Tacnet, C., Leroyer, C., et al. (2013) · European Respiratory Review · doi:10.1183/09059180.00008612 · Cited by 510
Nutritional supplementation for stable chronic obstructive pulmonary disease
Ferreira, I. M., Brooks, D., White, J., & Goldstein, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000998.pub3 · Cited by 326
Cachexia: A systemic consequence of progressive, unresolved disease
Ferrer, M., Anthony, T. G., Ayres, J. S., Biffi, G., Brown, J. C., Caan, B. J., Cespedes Feliciano, E. M., Coll, A. P., Dunne, R. F., Goncalves, M. D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.028 · Cited by 260
Metadata
- Authors
- Wagner, P. D.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2008-02-29
- Volume
- 31
- Issue
- 3
- Pages
- 492-501
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2159445530
- Cited by
- 280
- References
- 61
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.